The Journal of Urology · 2004 · 199 citations · 16 references
MedicinePediatricsPharmacologyPediatric Clinical PharmacologyPediatric TherapeuticsPharmaceutical ToxicologyBotulinum Toxin TherapyBotulinum Toxin TreatmentToxin-mediated DiseaseBotulinum NeurotoxinBotulinum ToxinsDetrusor Areflexia
PURPOSE: We prospectively evaluated the efficacy and durability of botulinum-A toxin in the treatment of detrusor hyperreflexia in children with myelomeningocele (MMC). MATERIALS AND METHODS: This study involved 15 patients with MMC (10 male and 5 female, mean age 5.8 years), all nonresponders to orally and intravesically administered anticholinergic medication and all on clean intermittent catheterization. Pretreatment assessment included a videourodynamic evaluation, an incontinence score and a mercaptoacetyltriglycine-3 renal scan. We injected 10 U/kg to a maximum of 360 U of botulinum-A toxin into the detrusor at 25 to 40 sites, sparing the trigone. Followup lasted between 12 and 30 months. All children underwent a urodynamic reevaluation, an assessment of the bladder capacity and an incontinence score at 3, 9 and 12 months after the first injection. A second intravesical injection was administered after 12 months and followup repeated as in the first year. RESULTS: After the first injection treatment mean bladder reflex volume increased from 72.00 +/- 28.12 ml to 298 +/- 32.45 ml (mean +/- SD, p <0.001). Maximum detrusor pressure decreased from 78.76 +/- 23.14 cm H2O to 42.76 +/- 24.34 cm H2O (p <0.001). Maximum bladder capacity increased from 136.34 +/- 45.71 ml to 297.02 +/- 87.17 ml (p <0.001). Detrusor compliance increased from 18.29 +/- 27.19 ml/cm H2O to 51.17 +/- 38.17 ml/cm H2O (p <0.001). Of the 15 patients 13 became completely dry with CIC. The remaining 2 patients improved from score 3 to 1. Results after 9 months were similar to those obtained after 3 months. Mean durability of the effect of the drug was 10.5 months after the first as well as after the second intravesical injection. CONCLUSIONS: Botulinum-A toxin is a safe alternative in the management of detrusor hyperreflexia in children with MMC. The preliminary results regarding urodynamic parameters and continence have been promising.
16
The standardisation of terminology of lower urinary tract function
Paul Abrams, Jerry G. Blaivas, Stuart L. Stanton et al. · World Journal of Urology · 1989 · 1.8K citations
Medicine, Physiology, Urology +12
Prognostic Value of Urodynamic Testing in Myelodysplastic Patients
Edward J. McGuire, Jeffrey R. Woodside, Thomas A. Borden et al. · The Journal of Urology · 1981 · 1.2K citations
Medicine, Urology, Female Urology +11
The Standardization of Terminology of Lower Urinary Tract Function
Patrick Bates, William E. Bradley, E. S. Glen et al. · The Journal of Urology · 1979 · 636 citations